2024-06-12 | Kronos Bio, Inc. KRON | PRESIDENT & CEO | 881,913 1.586% | $1.24 | $1.1M | -18.75% | ||
2024-06-11 | Kronos Bio, Inc. KRON | PRESIDENT & CEO | 744,308 1.1787% | $1.09 | $814,571 | -9.57% | ||
2024-06-10 | Kronos Bio, Inc. KRON | PRESIDENT & CEO | 1.38M 2.1146% | $0.88 | $1.21M | +10.41% | ||
2023-11-17 | Kronos Bio, Inc. KRON | President & CEO | 97,935 0.167% | $1.08 | $106,162 | +3.7% | ||
2023-11-16 | Kronos Bio, Inc. KRON | President & CEO | 262,433 0.4271% | $1.00 | $261,514 | +6.16% | ||
2023-11-15 | Kronos Bio, Inc. KRON | President & CEO | 1.37M 2.1008% | $0.80 | $1.1M | +24.43% | ||
2022-05-17 | Kronos Bio, Inc. KRON | President & CEO | 300,000 0.5131% | $3.78 | $1.13M | -36.55% | ||
2021-12-06 | Kronos Bio, Inc. KRON | President & CEO | 14,356 0.0258% | $12.09 | $173,492 | -60.68% | ||
2020-10-14 | Kronos Bio, Inc. KRON | President & CEO | 191,000 0.2434% | $19.00 | $3.63M | -14.59% | ||
2015-12-15 | Sale | Gilead Sciences, Inc. GILD | EVP, R&D and CSO | 70,000 0.0048% | $102.41 | $7.17M | -17.19% | |
2015-11-16 | Sale | Gilead Sciences, Inc. GILD | EVP, R&D and CSO | 140,000 0.0095% | $102.65 | $14.37M | -16.18% | |
2015-10-15 | Sale | Gilead Sciences, Inc. GILD | EVP, R&D and CSO | 140,000 0.0094% | $100.05 | $14.01M | -13.21% | |
2015-09-15 | Sale | Gilead Sciences, Inc. GILD | EVP, R&D and CSO | 140,000 0.0095% | $110.70 | $15.5M | -18.92% | |
2015-08-17 | Sale | Gilead Sciences, Inc. GILD | EVP, R&D and CSO | 140,000 0.0095% | $116.16 | $16.26M | -19.76% | |
2015-07-15 | Sale | Gilead Sciences, Inc. GILD | EVP, R&D and CSO | 132,522 0.0091% | $118.20 | $15.66M | -15.96% | |
2015-07-07 | Sale | Gilead Sciences, Inc. GILD | EVP, R&D and CSO | 7,478 0.0005% | $119.39 | $892,801 | -13.51% | |
2015-06-15 | Sale | Gilead Sciences, Inc. GILD | EVP, R&D and CSO | 140,000 0.0095% | $117.67 | $16.47M | -14.11% | |
2015-05-15 | Sale | Gilead Sciences, Inc. GILD | EVP, R&D and CSO | 140,000 0.0095% | $109.45 | $15.32M | -5.21% | |
2015-04-15 | Sale | Gilead Sciences, Inc. GILD | EVP, R&D and CSO | 140,000 0.0095% | $103.84 | $14.54M | +0.33% | |
2015-03-16 | Sale | Gilead Sciences, Inc. GILD | EVP, R&D and CSO | 140,000 0.0094% | $100.80 | $14.11M | +3.03% |